Hydrazines in glaucoma therapy

Details for Australian Patent Application No. 2009206587 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Dinh, Danny T.

Agent Davies Collison Cave

Pub. Number AU-A-2009206587

PCT Pub. Number WO2009/094286

Priority 61/023,365 24.01.08 US; 12/353,290 14.01.09 US

Filing date 15 January 2009

Wipo publication date 30 July 2009

International Classifications

C07D 333/40 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/5377 (2006.01)

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/094286 Priority application(s): WO2009/094286

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206588-IAP inhibitors

2009206580-Quinolizidinone M1 receptor positive allosteric modulators